What are the results of the Cryptogenic Stroke and Underlying Powers et al 2019 Guidelines for Management of AIS trial?
The results of the Cryptogenic Stroke and Underlying Powers et al 2019 Guidelines for Management of AIS trial indicated that long-term atrial fibrillation monitoring in cryptogenic stroke patients could help uncover potential atrial fibrillation beyond the short-term monitoring period. The results of the trial showed that anticoagulant therapies, such as aspirin, clopidogrel, and dipyridamole, were effective in reducing the risk of stroke recurrence and other heart-related complications. Additionally, echocardiography and carotid imaging were found to be cost-effective and beneficial for stroke management.  